A JAMA Psychiatry study explores the link between psychedelic use in adolescents and mental health, finding an association with fewer psychotic symptoms and a correlation with increased manic symptoms in those with genetic risks for schizophrenia or bipolar disorder.
Ayahuasca was found to speed up the extinction of fear memories in rats by affecting serotonin receptors in the brain. This effect, consistent across new and old memories, points to potential therapeutic uses for anxiety and trauma-related conditions.
A study revealed psilocybin diminishes the amygdala response to angry faces, potentially impacting emotion processing. This discovery underscores its potential for treating conditions like depression and anxiety, highlighting the profound effects of psychedelics on the brain.
MDMA enhances positive responses to social feedback without affecting negative responses. This sheds light on MDMA's potential in treating social processing impairments, spotlighting its unique empathogenic effects.
Studies reveal over 50% of ayahuasca users experience a personal death phenomenon, profoundly altering beliefs on consciousness and environmental concerns. These insights, derived from two studies, highlight the psychedelic's impact on spiritual growth and attitudes towards life and death.
A recent study explores psilocybin's effects on larval zebrafish, revealing it enhances exploratory behavior and buffers stress-induced activity changes, offering insights into psychedelic compounds' potential in mental health treatment.
DMT, a psychedelic, reduced depression symptoms in a study with experienced volunteers. The stronger the DMT experience, the greater the mental health benefits observed. However, results for anxiety and well-being were mixed, suggesting more research is needed to fully understand...
In work recently published in the Journal of Psychopharmacology, scientists have breathed new life into a decades-old tool for understanding the psychedelic experience, expanding our grasp of these profound states of mind. By reviving and updating the Psychedelic Experience Scale,...
Can groundbreaking treatments for depression and other psychiatric conditions come from substances once considered purely recreational or even taboo? A recent study by researchers at Johns Hopkins Medicine suggests the answer may be yes.
Interviews with clinicians reveal potential benefits of MDMA-assisted therapy for Borderline Personality Disorder (BPD), suggesting similarities with PTSD treatment. The study, published in the Journal of Psychedelic Studies, calls for further research into MDMA's efficacy for BPD.
New research suggests that psychedelics like LSD and psilocybin increase unusual visual phenomena, such as seeing with open eyes patterns or objects that are not actually present.
Low doses of MDMA may reduce challenging effects of LSD and psilocybin, increasing positive experiences like love and self-compassion, according to Scientific Reports. This supports the therapeutic potential of "candy flipping" and "hippy flipping."
MDMA-assisted therapy shows promise in enhancing emotional awareness and self-compassion in PTSD patients, areas typically unresponsive to conventional treatments.
New research in the European Journal of Psychotraumatology shows the therapeutic relationship's strength is key in MDMA-assisted psychotherapy for posttraumatic stress disorder (PTSD), indicating better outcomes with a stronger alliance.
A study on rats suggests that microdosing psilocybin could reduce stress-induced anhedonia and compulsive behaviors without causing anxiety or schizophrenia-like symptoms. This research offers insights into psilocybin's potential as a therapy for mental health disorders, though further human studies are...
PsyPost is a psychology and neuroscience news website dedicated to reporting the latest research on human behavior, cognition, and society. (READ MORE...)
To provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.